Company profile
Nova Leap Health Corp.
OTC: NVLPF · Healthcare · Medical - Care Facilities
Canadian filerHQ Halifax, NSReports USD
#494 of 1,418 Healthcare companies by revenue69th-percentile growth
EA Score
75B+FH 82DQ —GM 65SS 56
v0.1 · 45/100 weight · provisional
↑ Piotroski F, Altman-Z · ↓ listing tenure, 3-yr revenue growth
Methodology →Revenue TTM
$33.8M
Rev growth YoY (TTM)
+20.3%
Net income (FY)
-$193.2k
Employees
450
as of 2026-08-21
Market cap
$31.4M
as of 2026-08-21
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$32.0M$32.0M2025
Net income-$193.2k-$193.2k2025
Operating income$1.1M$1.1M2025
Total assets$23.4M$23.4M2025
Liabilities$4.4M$4.4M2025
Equity$19.0M$19.0M2025
Revenue trend
FY2018 – FY2025 · USD
FY18
FY19
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Nova Leap Health Corp.’s revenue?
Nova Leap Health Corp. booked $32.0M in FY2025 revenue, growing 24% year over year — faster than most Healthcare companies we track, at a -0.6% net margin.
Peers · Healthcare
Aoxing Pharmaceutical Company, Inc.——MediPharm Labs Corp.61CelectroCore, Inc.57CSonendo, Inc.——Cryo-Cell International, Inc.63CEyePoint Pharmaceuticals, Inc.58CKey facts
CEOChristopher Donald Dobbin
SectorHealthcare
IndustryMedical - Care Facilities
HeadquartersHalifax, NS
ExchangeOTC: NVLPF
Employees450
IPO date2019-07-12
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.